Bradley Foster & Sargent’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.2M Sell
284,705
-4,279
-1% -$494K 0.53% 49
2025
Q4
$30.4M Sell
288,984
-1,351
-0.5% -$127K 0.45% 52
2025
Q3
$24.4M Sell
290,335
-13,645
-4% -$1.12M 0.36% 67
2025
Q2
$24.1M Sell
303,980
-16,887
-5% -$1.34M 0.38% 63
2025
Q1
$28.8M Sell
320,867
-86,362
-21% -$8.06M 0.49% 50
2024
Q4
$40.5M Sell
407,229
-12,129
-3% -$1.25M 0.68% 42
2024
Q3
$47.6M Sell
419,358
-4,339
-1% -$515K 0.8% 36
2024
Q2
$52.5M Sell
423,697
-6,844
-2% -$882K 0.94% 31
2024
Q1
$56.8M Sell
430,541
-11,421
-3% -$1.41M 1.03% 33
2023
Q4
$48.2M Sell
441,962
-14,802
-3% -$1.54M 0.94% 33
2023
Q3
$52.7M Hold
456,764
1.11% 25
2023
Q2
$52.7M Sell
456,764
-103,606
-18% -$11.8M 1.11% 25
2023
Q1
$59.6M Sell
560,370
-3,244
-0.6% -$350K 1.42% 18
2022
Q4
$62.5M Buy
563,614
+1,049
+0.2% +$107K 1.57% 17
2022
Q3
$48.4M Buy
562,565
+594
+0.1% +$53K 1.34% 22
2022
Q2
$51.2M Buy
561,971
+1,408
+0.3% +$125K 1.32% 21
2022
Q1
$46M Sell
560,563
-438
-0.1% -$34.5K 0.98% 29
2021
Q4
$43M Buy
561,001
+5,464
+1% +$435K 0.89% 36
2021
Q3
$41.7M Sell
555,537
-5,271
-0.9% -$401K 0.98% 30
2021
Q2
$43.6M Sell
560,808
-41,754
-7% -$3.11M 1.02% 29
2021
Q1
$44.3M Sell
602,562
-22,351
-4% -$1.65M 1.12% 24
2020
Q4
$48.8M Buy
624,913
+15,714
+3% +$1.2M 1.29% 24
2020
Q3
$48.2M Buy
+609,199
New +$47.7M 1.41% 23
2020
Q1
$44.4M Sell
604,665
-1,624
-0.3% -$128K 1.78% 12
2019
Q4
$52.6M Sell
606,289
-1,757
-0.3% -$144K 1.62% 15
2019
Q3
$48.8M Sell
608,046
-8,380
-1% -$672K 1.63% 15
2019
Q2
$49.3M Sell
616,426
-24,030
-4% -$1.84M 1.63% 15
2019
Q1
$50.8M Sell
640,456
-12,079
-2% -$903K 1.77% 11
2018
Q4
$47.6M Sell
652,535
-4,447
-0.7% -$314K 1.92% 12
2018
Q3
$44.5M Sell
656,982
-5,526
-0.8% -$352K 1.51% 15
2018
Q2
$38.4M Sell
662,508
-17,891
-3% -$1.01M 1.37% 19
2018
Q1
$35.4M Sell
680,399
-50,899
-7% -$2.75M 1.34% 17
2017
Q4
$39.3M Sell
731,298
-56,688
-7% -$3.14M 1.42% 16
2017
Q3
$48.1M Sell
787,986
-3,268
-0.4% -$198K 1.83% 8
2017
Q2
$48.4M Sell
791,254
-9,860
-1% -$600K 1.94% 9
2017
Q1
$48.6M Sell
801,114
-6,722
-0.8% -$408K 1.96% 9
2016
Q4
$45.4M Buy
807,836
+137,289
+20% +$8.03M 1.93% 9
2016
Q3
$39.9M Buy
670,547
+3,727
+0.6% +$218K 1.75% 14
2016
Q2
$36.7M Buy
666,820
+4,118
+0.6% +$219K 1.64% 17
2016
Q1
$33.5M Buy
662,702
+9,635
+1% +$472K 1.55% 16
2015
Q4
$32.9M Buy
653,067
+20,048
+3% +$1.01M 1.51% 16
2015
Q3
$29.8M Buy
633,019
+91,573
+17% +$4.86M 1.47% 18
2015
Q2
$29.4M Buy
541,446
+120,728
+29% +$6.77M 1.34% 19
2015
Q1
$23.1M Buy
420,718
+15,067
+4% +$853K 1.05% 25
2014
Q4
$22M Sell
405,651
-1,050
-0.3% -$58.5K 1.04% 29
2014
Q3
$23M Sell
406,701
-2,152
-0.5% -$121K 1.09% 24
2014
Q2
$22.6M Buy
408,853
+23,566
+6% +$1.29M 1.1% 27
2014
Q1
$20.9M Buy
385,287
+9,490
+3% +$491K 1.08% 28
2013
Q4
$17.9M Sell
375,797
-68,634
-15% -$3.14M 0.95% 30
2013
Q3
$20.2M Buy
444,431
+11,343
+3% +$518K 1.18% 25
2013
Q2
$19.2M Buy
+433,088
New +$19.3M 1.19% 23

Other funds holding MRK

Bradley Foster & Sargent's MRK Position: Q1 2026 in Review

Bradley Foster & Sargent reduced its Merck (MRK) stake by 1.5% in Q1 2026, selling an estimated $494K and leaving 284,705 shares worth $34.2M. The position accounts for 0.53% of the portfolio, ranked #49.

Bradley Foster & Sargent first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $62.5M in Q4 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bradley Foster & Sargent held 284,705 shares of Merck worth $34.2M as of Q1 2026.
  • Bradley Foster & Sargent sold 4,279 Merck shares in Q1 2026, an estimated $494K.
  • Merck made up 0.53% of Bradley Foster & Sargent's portfolio in Q1 2026, its #49 holding.
  • Bradley Foster & Sargent first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Bradley Foster & Sargent's Merck position peaked at $62.5M in Q4 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.